Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAJLJ8WuczC6uwrh7JfdKAEvqA8m-7bcSOdeAELOqKiCM#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- association type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- context type Cohort assertion.
- DB00363 type Drug assertion.
- MONDO_0005414 type Disease assertion.
- association label "There are no FDA or manufacturer guidelines for use of clozapine in pediatric population. Clozapine has been used in the treatment of refractory schizophrenia in child and adolescents. It is estimated that 40%–50% of patients with very early-onset schizophrenia (VEOS) are nonresponders to first-line neuroleptics and that clozapine is likely to be beneficial." assertion.
- context label "Children and adolescents" assertion.
- DB00363 label "Clozapine" assertion.
- MONDO_0005414 label "Schizophrenia" assertion.
- association object MONDO_0005414 assertion.
- association predicate treats assertion.
- association category ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- context category Cohort assertion.
- DB00363 category Drug assertion.
- MONDO_0005414 category Disease assertion.
- association subject DB00363 assertion.
- association publications 31082865 assertion.
- association has_population_context context assertion.
- association relation NCIT_C94303 assertion.
- association aggregator_knowledge_source knowledge-collaboratory assertion.